Company Performance: Revenue, profitability, and sales growth significantly impact investor confidence and stock value. Strong financials often lead to price increases.

Regulatory News: FDA approvals, clinical trial outcomes, and changes in regulations regarding meningitis vaccines directly influence market perception and stock performance.

Market Sentiment: Overall market trends and investor confidence in the pharmaceutical sector play a crucial role. Positive sentiment can drive up the stock, while negative sentiment can decrease it.

Competition: Activities of competitors, introduction of new vaccines, and competitive pricing strategies can affect the market share and thus, the stock price.

Global Health Events: Outbreaks of meningitis or related diseases globally can increase demand for vaccines and drive up the stock price.

Economic Conditions: Economic recessions or booms can indirectly affect the healthcare industry and consumer spending, impacting the demand for vaccines and influencing the stock.

News & Announcements: Company announcements, press releases, and media coverage regarding the company's products, partnerships, and future plans have a substantial effect.